eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2015
vol. 19
 
Share:
Share:
abstract:
Review paper

Current concepts in diagnosis and treatment of chronic lymphocytic leukemia

Iwona Hus
,
Jacek Roliński

Contemp Oncol (Pozn) 2015; 19 (5): 361-367
Online publish date: 2015/12/22
View full text Get citation
 
PlumX metrics:
Chronic lymphocytic leukemia (CLL) is the most commonly diagnosed type of leukemia in Western Europe and North America, and represents about 30% of all leukemias in adults. Chronic lymphocytic leukemia is a disease of the elderly, who are often in poorer general health and burdened with multiple comorbidities. These factors affect the decision making when choosing an appropriate method of treatment.

In recent years there has been significant progress in the treatment of chronic lymphocytic leukemia, first due to the introduction of immunochemotherapy with monoclonal antibodies and latterly small molecules, like tyrosine kinase inhibitors targeting B-cell receptor signaling. This article discusses the current diagnostic principles, the most important prognostic factors and therapeutic options, available in first-line treatment and in refractory/resistant disease, including high-risk CLL, both for patients with good and those with poor performance status. It also presents important novel molecules which have been evaluated in clinical trials.
keywords:

chronic lymphocytic leukemia, clinical symptoms, diagnosis, prognostic factors, treatment

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.